Aratana Therapeutics Inc (NASDAQ:PETX)

14.69
Delayed Data
As of Jul 06
 +0.52 / +3.67%
Today’s Change
9.20
Today|||52-Week Range
20.63
-17.56%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 26.00, with a high estimate of 38.00 and a low estimate of 23.00. The median estimate represents a +76.99% increase from the last price of 14.69.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.38
Sales
$269.0K
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -44.71%
 
 
 
 
 
 
Growthannually -14.23%
 
 
 
 
 

Sales

Growthquarterly 72.42%
 
 
 
 
 
 
Growthannually 69.55%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account